BG Medicine Inc
OTC:BGMD
Cash Flow Statement
Cash Flow Statement
BG Medicine Inc
| Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(25)
|
(18)
|
(17)
|
(15)
|
(16)
|
(16)
|
(18)
|
(22)
|
(24)
|
(26)
|
(24)
|
(22)
|
(20)
|
(17)
|
(16)
|
(13)
|
(10)
|
(9)
|
(8)
|
(7)
|
(7)
|
(6)
|
(5)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
5
|
4
|
5
|
4
|
3
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(5)
|
0
|
1
|
(0)
|
1
|
0
|
0
|
2
|
2
|
2
|
(0)
|
(1)
|
(2)
|
(3)
|
(1)
|
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
0
|
1
|
0
|
|
| Cash from Operating Activities |
(25)
N/A
|
(13)
+48%
|
(11)
+12%
|
(11)
+6%
|
(11)
-6%
|
(13)
-15%
|
(15)
-14%
|
(17)
-16%
|
(19)
-8%
|
(20)
-8%
|
(21)
-5%
|
(20)
+7%
|
(19)
+4%
|
(18)
+8%
|
(15)
+13%
|
(13)
+12%
|
(11)
+15%
|
(10)
+17%
|
(8)
+15%
|
(7)
+12%
|
(5)
+25%
|
(4)
+33%
|
(4)
-1%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
10
|
8
|
2
|
1
|
(12)
|
(14)
|
0
|
0
|
13
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
9
N/A
|
8
-14%
|
2
-75%
|
1
-33%
|
(13)
N/A
|
(14)
-14%
|
(0)
+99%
|
(0)
-72%
|
13
N/A
|
14
+11%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-60%
|
(0)
-244%
|
(0)
N/A
|
(0)
+91%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
37
|
37
|
38
|
38
|
1
|
1
|
1
|
1
|
14
|
13
|
13
|
13
|
0
|
10
|
10
|
9
|
9
|
0
|
5
|
5
|
|
| Net Issuance of Debt |
0
|
3
|
5
|
3
|
3
|
2
|
(0)
|
10
|
10
|
10
|
10
|
(0)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
|
| Other |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
(0)
N/A
|
2
N/A
|
4
+112%
|
39
+1 012%
|
39
-1%
|
38
-3%
|
37
-3%
|
10
-73%
|
10
+6%
|
11
+1%
|
10
-3%
|
13
+25%
|
12
-3%
|
11
-8%
|
10
-10%
|
(3)
N/A
|
5
N/A
|
5
-8%
|
5
0%
|
5
N/A
|
(4)
N/A
|
(0)
+98%
|
1
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||
| Net Change in Cash |
(16)
N/A
|
(3)
+79%
|
(6)
-73%
|
30
N/A
|
15
-50%
|
10
-30%
|
21
+109%
|
(8)
N/A
|
4
N/A
|
4
+1%
|
(11)
N/A
|
(7)
+38%
|
(7)
+4%
|
(6)
+6%
|
(5)
+19%
|
(17)
-234%
|
(7)
+60%
|
(5)
+24%
|
(4)
+28%
|
(3)
+27%
|
(9)
-255%
|
(4)
+61%
|
(3)
+29%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(26)
N/A
|
(13)
+49%
|
(11)
+12%
|
(11)
+6%
|
(12)
-6%
|
(13)
-15%
|
(15)
-14%
|
(18)
-17%
|
(19)
-8%
|
(20)
-8%
|
(21)
-5%
|
(20)
+7%
|
(19)
+4%
|
(18)
+7%
|
(15)
+13%
|
(13)
+13%
|
(11)
+15%
|
(10)
+16%
|
(8)
+15%
|
(7)
+12%
|
(5)
+25%
|
(4)
+33%
|
(4)
-1%
|
|